Stock A115450 HLB THERAPEUTICS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases HLB Therapeutics Co.,Ltd.

Equities

A115450

KR7115450009

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
6,990 KRW +4.02% Intraday chart for HLB Therapeutics Co.,Ltd. +0.87% +59.41%
05-16 HLB Therapeutics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-01 HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RegeneRx Biopharmaceuticals, Inc. - First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical trial with RGN-259
AQ
RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A115450 Stock
  4. News HLB Therapeutics Co.,Ltd.
  5. Press Releases